SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?   |   

 Novartis AG  (NVS)     Rate NVS  -  Discuss NVS  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Major Drugs
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
82.5%
Top:
33.0%
Rate NVS:


Home
Quotes
Bull or Bear
Who's Rated NVS
Discuss
        

NVS: Bull or Bear?

Novartis: An ex-US Proxy for Global Healthcare Graphic_rating_buy NVS
Rxlogo
65%
 -9.59%
in 42 days

In mid-July, Novartis (NVS) reported better-than-expected financial results for Q208 due to sales growth of 14% (which included a 9% forex benefit thanks to a weak US Dollar), resulting in an EPS of $0.98 for the quarter. Pharmaceutical sales were driven by strong demand for the blood pressure drug Diovan, which faces generic competition in 2012, and cancer drugs such as Gleevac, Zometa, and Femara. Novartis is expected to file for regulatory approval of cancer drug Afinitor by the end of this year. As illustrated in the accompanying five-year chart, Novartis has outperformed bo
...
By  Mike Havrilla   (-5.01%  risk: aggressive)  07/26/08 Comment


Bullish on NVS ... Graphic_rating_buy NVS
Foto
46%
 -6.11%
in 56 days
Analysts' Recommendation: Buy 30 Days Ago: Buy Analysts' Target: $49 Analysts' Targets HSBC Securities $49 Add Thursday, June 12, 2008 BusinessWeek Rankings Best Global Brands Best Global Brands 2006 #43 2005 #43 Novartis AG provides healthcare solutions that address the needs of patients and societies worldwide. Its Pharmaceuticals division researches, develops, manufactures, distributes, and sells pharmaceuticals in therapeutic areas, including cardiovascular and metabolism; oncology and hematology; neuroscience; respiratory; infectious diseases, tra...
By  Marian Filo   (-4.25%  risk: conservative)  07/12/08 Comment


Novartis (NVS): 'Best pipeline in the business' Graphic_rating_buy NVS
32%
 -5.57%
in 65 days

"The pipelines of most Big Pharmas are bone dry; last year, the FDA approved the lowest number of new drugs (19) since 1983," notes Louis Basenese, contributing editor to the industry-leading The Oxford Club.

"But opportunity always lurks in the wreckage, and one Big Pharma, in particular, is being unfairly punished." Here's his bullish outlook on Novartis (NYSE: NVS), which he calls the "only Big Pharma worth owning."

"Unlike others in the sector, Novartis doesn't suffer from an empty pipeline. It's launched more drugs globally than any other firm in the past seven years. It has more than 10

...
By  The Stock Advisors   (-7.90%  risk: conservative)  07/03/08 Comment


Get free stock alert for NVS:
Your Email Address:


Good growth in Drugs Graphic_rating_buy NVS
Buddy_icon
20%
 -9.17%
in 241 days
In my opinion, global large-cap pharmacueticial stocks, including Pfizer , Novartis , Astrazenca , GlaxoSmithKline , Wyeth and Eli Lilly are currently substantially undervalued.  These companies are currently paying out huge dividends and trading at sensible P/Es.  Unlike their small-cap high-risk research counterparts, these blue-chip stocks represent strong, yet low risk growth.  Why risk your money on an obscure new cure for bird-flu, from a dodgy one-man company, when you don't have to?

While sales of their products may be slowing in the OECD developed world, ...
By  shanehalloran.wordpress.com   (-5.10%  risk: conservative)  01/09/08 Comment


Bullish on NVS ... Graphic_rating_buy NVS
N/A
 -3.91%
in 835 days
Buy Report: Novartis AG ADR (NYSE: NVS) prepared 20060417 Key Stats: Last Close: $55.81 Market Cap $Mil: 130,368 Sales $Mil: 35,526 About Novartis: - Latin for “New Arts,� Novartis is a Switzerland-based manufacturer of pharmaceutical, health-care, and vision products. The firm was formed in 1996 by the merger of Ciba-Geigy and Sandoz. Areas of specialty in branded drugs include oncology and cardiovascular products. Consumer health-care brands include such familiar names as Ex-Lax, Maalox, Lamisil, and Gerber. Its Ceiba-Geigy division makes disposable contact lenses as well as heal...
By  mrefranklin   (-5.58%  risk: conservative)  05/25/06 Comment





People Bullish on NVS

Rxlogo
Mike Havrilla
Sr. Associate
65%
about 1 mo ago

Foto
Marian Filo
Principal
46%
about 1 mo ago

The Stock Advisors
Analyst
32%
2 mos ago

nlwong73
Analyst
65%
2 mos ago

kcmcc
Analyst
52%
2 mos ago


People Bearish on NVS

04obama650
cambridgekore
Analyst
82%
about 1 mo ago

ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 akiralegrand 11.64 +15.11% 15
2 noshoes 11.28 +19.14% 52
3 The Big Bear 10.31 +20.63% 163
4 dumela 9.63 +18.49% 1
5 Gerald Greene 8.91 +19.68% 21


POPULAR STOCKS
Symbol Company Name Sentiment
WMT WalMart Stores Inc
GE General Electric Company
F Ford Motor Company
T AT&T Inc
BIDU Baiducom Inc ADS
NVDA NVIDIA Corp

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Get Free Alert for NVS:



Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About Novartis AG - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch